159 related articles for article (PubMed ID: 17236225)
1. Common polymorphisms in 5-lipoxygenase and 12-lipoxygenase genes and the risk of incident, sporadic colorectal adenoma.
Gong Z; Hebert JR; Bostick RM; Deng Z; Hurley TG; Dixon DA; Nitcheva D; Xie D
Cancer; 2007 Mar; 109(5):849-57. PubMed ID: 17236225
[TBL] [Abstract][Full Text] [Related]
2. Platelet 12-lipoxygenase Arg261Gln polymorphism: functional characterization and association with risk of esophageal squamous cell carcinoma in combination with COX-2 polymorphisms.
Guo Y; Zhang X; Tan W; Miao X; Sun T; Zhao D; Lin D
Pharmacogenet Genomics; 2007 Mar; 17(3):197-205. PubMed ID: 17460548
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms in TP53, nonsteroidal anti-inflammatory drugs and the risk of colorectal cancer: evidence for gene-environment interaction?
Tan XL; Nieters A; Hoffmeister M; Beckmann L; Brenner H; Chang-Claude J
Pharmacogenet Genomics; 2007 Aug; 17(8):639-45. PubMed ID: 17622940
[TBL] [Abstract][Full Text] [Related]
4. Prostacyclin synthase and arachidonate 5-lipoxygenase polymorphisms and risk of colorectal polyps.
Poole EM; Bigler J; Whitton J; Sibert JG; Potter JD; Ulrich CM
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):502-8. PubMed ID: 16537708
[TBL] [Abstract][Full Text] [Related]
5. Associations of functional polymorphisms in cyclooxygenase-2 and platelet 12-lipoxygenase with risk of occurrence and advanced disease status of colorectal cancer.
Tan W; Wu J; Zhang X; Guo Y; Liu J; Sun T; Zhang B; Zhao D; Yang M; Yu D; Lin D
Carcinogenesis; 2007 Jun; 28(6):1197-201. PubMed ID: 17151091
[TBL] [Abstract][Full Text] [Related]
6. Inflammation-related gene polymorphisms and colorectal adenoma.
Gunter MJ; Canzian F; Landi S; Chanock SJ; Sinha R; Rothman N
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1126-31. PubMed ID: 16775170
[TBL] [Abstract][Full Text] [Related]
7. PTGS2 (COX-2) -765G > C promoter variant reduces risk of colorectal adenoma among nonusers of nonsteroidal anti-inflammatory drugs.
Ulrich CM; Whitton J; Yu JH; Sibert J; Sparks R; Potter JD; Bigler J
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):616-9. PubMed ID: 15767339
[TBL] [Abstract][Full Text] [Related]
8. The PPAR{gamma} Pro12Ala polymorphism and risk for incident sporadic colorectal adenomas.
Gong Z; Xie D; Deng Z; Bostick RM; Muga SJ; Hurley TG; Hebert JR
Carcinogenesis; 2005 Mar; 26(3):579-85. PubMed ID: 15564289
[TBL] [Abstract][Full Text] [Related]
9. Colorectal adenoma risk is modified by the interplay between polymorphisms in arachidonic acid pathway genes and fish consumption.
Siezen CL; van Leeuwen AI; Kram NR; Luken ME; van Kranen HJ; Kampman E
Carcinogenesis; 2005 Feb; 26(2):449-57. PubMed ID: 15550453
[TBL] [Abstract][Full Text] [Related]
10. Methionine synthase A2756G polymorphism interacts with alcohol and folate intake to influence the risk of colorectal adenoma.
Yamaji T; Iwasaki M; Sasazuki S; Sakamoto H; Yoshida T; Tsugane S
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):267-74. PubMed ID: 19124508
[TBL] [Abstract][Full Text] [Related]
11. Epoxide hydrolase polymorphisms, cigarette smoking and risk of colorectal adenoma in the Nurses' Health Study and the Health Professionals Follow-up Study.
Tranah GJ; Giovannucci E; Ma J; Fuchs C; Hankinson SE; Hunter DJ
Carcinogenesis; 2004 Jul; 25(7):1211-8. PubMed ID: 14988221
[TBL] [Abstract][Full Text] [Related]
12. Polymorphism of the cyclin D1 gene, CCND1, and risk for incident sporadic colorectal adenomas.
Lewis RC; Bostick RM; Xie D; Deng Z; Wargovich MJ; Fina MF; Roufail WM; Geisinger KR
Cancer Res; 2003 Dec; 63(23):8549-53. PubMed ID: 14679024
[TBL] [Abstract][Full Text] [Related]
13. Increased risk of colorectal adenomas in Italian subjects carrying the p53 PIN3 A2-Pro72 haplotype.
Perfumo C; Bonelli L; Menichini P; Inga A; Gismondi V; Ciferri E; Percivale P; Bianchi Scarrà G; Nasti S; Fronza G; Varesco L
Digestion; 2006; 74(3-4):228-35. PubMed ID: 17374954
[TBL] [Abstract][Full Text] [Related]
14. Twenty-four non-synonymous polymorphisms in the one-carbon metabolic pathway and risk of colorectal adenoma in the Nurses' Health Study.
Hazra A; Wu K; Kraft P; Fuchs CS; Giovannucci EL; Hunter DJ
Carcinogenesis; 2007 Jul; 28(7):1510-9. PubMed ID: 17389618
[TBL] [Abstract][Full Text] [Related]
15. Low-penetrance genes and their involvement in colorectal cancer susceptibility.
de Jong MM; Nolte IM; te Meerman GJ; van der Graaf WT; de Vries EG; Sijmons RH; Hofstra RM; Kleibeuker JH
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1332-52. PubMed ID: 12433710
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in PTGS1 (=COX-1) and risk of colorectal polyps.
Ulrich CM; Bigler J; Sparks R; Whitton J; Sibert JG; Goode EL; Yasui Y; Potter JD
Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):889-93. PubMed ID: 15159324
[TBL] [Abstract][Full Text] [Related]
17. APC Asp1822Val and Gly2502Ser polymorphisms and risk of colorectal cancer and adenoma.
Tranah GJ; Giovannucci E; Ma J; Fuchs C; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):863-70. PubMed ID: 15824157
[TBL] [Abstract][Full Text] [Related]
18. [Application of multifactor dimensionality reduction on the interactions between gene-gene, gene-environment and the risk sporadic colorectal cancer in Chinese population].
Jin MJ; Liu B; Zhang SS; Zhang YJ; Xu M; Ma XY; Yao KY; Chen K
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jun; 29(6):535-9. PubMed ID: 19040031
[TBL] [Abstract][Full Text] [Related]
19. Contribution of cyclin d1 (CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancer.
Porter TR; Richards FM; Houlston RS; Evans DG; Jankowski JA; Macdonald F; Norbury G; Payne SJ; Fisher SA; Tomlinson I; Maher ER
Oncogene; 2002 Mar; 21(12):1928-33. PubMed ID: 11896626
[TBL] [Abstract][Full Text] [Related]
20. [Association of TP53 gene polymorphisms with genetic susceptibility to liver metastases of colorectal cancer].
Wang AZ; Zhu ZZ; Cong WM
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):168-71. PubMed ID: 18393238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
